Summary:
Clinical trials, and the volunteers who participate in them, are vital
to creating vaccines. Vaccines aim to safely protect people against
infections. The purpose of this clinical trial is to assess the safety and
efficacy of an investigational vaccine (a vaccine not yet approved
by a country’s drug regulatory agency) aimed at preventing RSV
infection in women and men over 60.
Qualified Participants Must:
• 60 years of age or older
•
In good health
•
Certain chronic diseases such as heart failure and chronic obstructive pulmonary disease may be permissible
•
Primarily responsible for self-care (do not require a caretaker)
Qualified Participants May Receive:
$50 per visit (10 visits total)
$500 to $600 for duration of study
Transportation available